PLX

#3115
Protalix BioTherapeutics, Inc. Common Stock
2.8300 USD
+1.07%
Sector: Atención Sanitaria
Básica: USD
Profit Currency: USD
Rango diario
2.7890
2.8450
Rango anual
2.5850
3.1900
Cambio diario
+1.07%
Monthly Change
-3.08%
6 month change
-3.08%
Cambio anual
-3.08%
Cierres anteriores
2.8000
Open
2.8200
Bid
2.8300
Ask
2.8330
Low
2.7890
High
2.8450
Volumen
288
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20202021202220232024

Protalix BioTherapeutics Inc (DE)

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.

Noticias